| Code | CSB-MP012928HU-WD |
| Abbreviation | Recombinant Human LIF protein (Active) |
| MSDS | |
| Size | Inquiry |
| Order now | |
| Image | |
| Have Questions? | Leave a Message or Start an on-line Chat |
Leukemia inhibitory factor governs pluripotency maintenance in embryonic stem cells and drives differentiation in hematopoietic lineages, making precise control of its signaling essential in both stem cell biology and immunology experiments. This tag-free preparation, spanning the full mature sequence (aa 23–202), demonstrates potent bioactivity with an ED50 ≤0.2 ng/ml in the M1 myeloid leukemia cell differentiation assay, providing a quantitative benchmark for dose-response studies in cell fate decisions and JAK/STAT pathway activation experiments. The endotoxin specification of ≤10 EU/mg aligns with standards expected in primary immune cell cultures and hematopoietic differentiation protocols, where LPS contamination would confound cytokine-specific responses. Purity exceeding 95% by SDS-PAGE, combined with the validated differentiation activity, supports use in functional assays examining lineage commitment, in antibody development workflows requiring a native immunogen, and as a reference standard in LIF detection platforms.
There are currently no reviews for this product.